Stock Taper
INDP
INDAPTUS THERAPEUTICS, INC.
NASDAQ
$1.14
▼ DOWN 1.72% (-0.02)

KEY STATISTICS

Market Cap$129.10 M
52w High$8.57
52w Low$0.92
Dividend Yield
Frequency
P/E-0.07
Volume102.97K
Shares Out.113.24M

COMPANY

LEADERSHIP

Junyi Dai
CHIEF EXECUTIVE
Junyi Dai

COMPENSATION 2026

Salary$0
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$0

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 4, 2015
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
5

UPCOMING EARNINGS

DateNov 17, 2026
DayTuesday
Rev. Est.
NOV
17
TUE

SPLIT RECORD

DATETYPERATIO
2025-06-27Reverse1:28
2021-07-27Reverse1:4
2020-10-30Reverse1:20

PRICE

$1.14 ▼ DOWN 1.72% (−$0.02)
OVERLAYS
$1.12$1.14$1.169:41 AM10:44 AM11:47 AM12:50 PM1:53 PM2:56 PM3:59 PM1.14

About Indaptus Therapeutics, Inc.

https://indaptusrx.com ↗

Indaptus Therapeutics, Inc., a New York-based pre-clinical biotech, develops anti-cancer and anti-viral immunotherapies, with its lead candidate Decoy20 in Phase I trials for various cancers and viral infections.

INDUSTRY

Biotechnology

A PRODUCT INDAPTUS THERAPEUTICS, INC. IS KNOWN FOR

Decoy20
Decoy20

Decoy20, Indaptus Therapeutics' lead immunotherapy in Phase 1 trials, uses proprietary bacteria-based technology to activate immune responses against advanced solid tumors and infections.

COMPETITORS

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
0.04%
HOLDERS
2
TOP 2 OF 2 · RANKED BY POSITION SIZE
Pine Valley Investments Ltd Liability Co
43.9K sh · $36.99K
Reilly Financial Advisors, LLC
63 sh · $0

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

DIRECTOR:
Lu Qinglai
· —
2026-04-08
OFFICER: CHIEF EXECUTIVE OFFICER
Dai Junyi
· —
2026-03-23
10 PERCENT OWNER
Yao Yun
· —
2026-03-23
10 PERCENT OWNER
SINO LION VENTURES Ltd
· —
2026-03-23

SECTORS PEERS

PEERPRICE
GTBP$0.30COMPARE
REVB$1.05COMPARE
PTIX$0.98COMPARE
ATXI$0.45COMPARE
NKGN$0.00COMPARE
SLXN$0.36COMPARE
PBM$4.21COMPARE
LIPO$0.00COMPARE